Jianjiao H. Wang
246 Xuefu Road
Harbin, 150086, China
Harbin, 150086, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
TRIM21-mediated degradation of HILPDA overcomes anti-PD-1 immunotherapy resistance in breast cancer by limiting PD-L1 palmitoylation.
Journal: Oncogene
Published: September 17, 2025
Retraction: MicroRNA-300 inhibited glioblastoma progression through ROCK1.
Journal: Oncotarget
Published: April 24, 2025
Long Non-coding RNA EPIC1 Promotes Cell Proliferation and Motility and Drug Resistance in Glioma.
Journal: Molecular therapy oncolytics
Published: February 24, 2020
Cytosine 5-hydroxymethylation regulated kit gene expression in acute myeloid leukemia.
Journal: Journal of biological regulators and homeostatic agents
Published: April 12, 2019
Overexpression of circular RNA circ-CDC45 facilitates glioma cell progression by sponging miR-516b and miR-527 and predicts an adverse prognosis.
Journal: Journal of cellular biochemistry
Published: April 11, 2019
miR‑342 inhibits glioma cell proliferation by targeting GPRC5A.
Journal: Molecular medicine reports
Published: November 02, 2018
MicroRNA-365 suppressed cell proliferation and migration via targeting PAX6 in glioblastoma.
Journal: American journal of translational research
Published: June 10, 2018
Cdc20 overexpression is involved in temozolomide-resistant glioma cells with epithelial-mesenchymal transition.
Journal: Cell cycle (Georgetown, Tex.)
Published: November 08, 2017
Genipin Inhibits LPS-Induced Inflammatory Response in BV2 Microglial Cells.
Journal: Neurochemical research
Published: December 10, 2016
miR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2.
Journal: Biochemical and biophysical research communications
Published: November 03, 2015
MicroRNA-300 inhibited glioblastoma progression through ROCK1.
Journal: Oncotarget
Published: September 06, 2015
Last Updated: 09/26/2026